Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Pharmacoeconomics|September 10, 2025
Eco Friendly and Budget Smart: An Economic and Environmental Evaluation of Alternative PD-1 and PD-L1 Inhibitor Dosing RegimensLeo Karlsson, Joseph Ciccolini, Rob Ter Heine, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 22, 2019
[Medication safety in trials is not sufficiently guaranteed]Kaylee R M Ferrier, C Kramers, Rob Ter Heine
Nederlands Tijdschrift Voor Geneeskunde|July 28, 2022
[CYP3A inhibitors as a pharmacokinetic enhancer: pros and cons of drug interactions]David M Burger, P H van Erp, Rob Ter Heine
Therapeutic Drug Monitoring|February 16, 2022
Meropenem to Treat Valproic Acid IntoxicationElise J Smolders, Rob Ter Heine, Stephanie Natsch, et al.
Clinical Chemistry and Laboratory Medicine|May 21, 2010
A less sensitive detector does not necessarily result in a less sensitive method: fast quantification of 13 antiretroviral analytes in plasma with liquid chromatography coupled with tandem mass spectrometryRob Ter Heine, Hilde Rosing, Jos H Beijnen, et al.
International Journal of Antimicrobial Agents|June 24, 2020
Personalised antimicrobial dosing: standing on the shoulders of giantsEveline Wallenburg, Rob Ter Heine, Jeroen A Schouten, et al.
International Journal of Antimicrobial Agents|November 26, 2018
Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimenSarah Wilkes, Inge van Berlo, Jaap Ten Oever, et al.
Pediatric Nephrology (Berlin, Germany)|March 18, 2018
Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndromeAnne M Schijvens, Rob Ter Heine, Saskia N de Wildt, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2018
Caspofungin dosage adjustments are not required for patients with Child-Pugh B or C cirrhosisThierry Gustot, Rob Ter Heine, Elisa Brauns, et al.
Journal of Clinical Lipidology|March 26, 2023
Individualized dosing of evinacumab is predicted to yield reductions in drug expensesRob Ter Heine, Gerard A Rongen, Jeanine Roeters van Lennep, et al.
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Pharmacoeconomics|September 10, 2025
Eco Friendly and Budget Smart: An Economic and Environmental Evaluation of Alternative PD-1 and PD-L1 Inhibitor Dosing RegimensLeo Karlsson, Joseph Ciccolini, Rob Ter Heine, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 22, 2019
[Medication safety in trials is not sufficiently guaranteed]Kaylee R M Ferrier, C Kramers, Rob Ter Heine
Nederlands Tijdschrift Voor Geneeskunde|July 28, 2022
[CYP3A inhibitors as a pharmacokinetic enhancer: pros and cons of drug interactions]David M Burger, P H van Erp, Rob Ter Heine
Therapeutic Drug Monitoring|February 16, 2022
Meropenem to Treat Valproic Acid IntoxicationElise J Smolders, Rob Ter Heine, Stephanie Natsch, et al.
Clinical Chemistry and Laboratory Medicine|May 21, 2010
A less sensitive detector does not necessarily result in a less sensitive method: fast quantification of 13 antiretroviral analytes in plasma with liquid chromatography coupled with tandem mass spectrometryRob Ter Heine, Hilde Rosing, Jos H Beijnen, et al.
International Journal of Antimicrobial Agents|June 24, 2020
Personalised antimicrobial dosing: standing on the shoulders of giantsEveline Wallenburg, Rob Ter Heine, Jeroen A Schouten, et al.
International Journal of Antimicrobial Agents|November 26, 2018
Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimenSarah Wilkes, Inge van Berlo, Jaap Ten Oever, et al.
Pediatric Nephrology (Berlin, Germany)|March 18, 2018
Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndromeAnne M Schijvens, Rob Ter Heine, Saskia N de Wildt, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2018
Caspofungin dosage adjustments are not required for patients with Child-Pugh B or C cirrhosisThierry Gustot, Rob Ter Heine, Elisa Brauns, et al.
Journal of Clinical Lipidology|March 26, 2023
Individualized dosing of evinacumab is predicted to yield reductions in drug expensesRob Ter Heine, Gerard A Rongen, Jeanine Roeters van Lennep, et al.
Pageof 16